Citi Starts PRA Health Sciences (PRAH) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
UPDATE: Credit Suisse Starts PRA Health Sciences (PRAH) at Outperform
December 8, 2014 9:23 AM EST(Updated - December 8, 2014 10:30 AM EST)
Credit Suisse initiated coverage on PRA Health Sciences (NASDAQ: PRAH) with an Outperform rating and a price target of $27.00.
"PRAH is a global clinical contract research organization (CRO) that provides outsourced services to support all stages of the clinical... More
UBS Starts PRA Health Sciences (PRAH) at Buy
December 8, 2014 7:55 AM ESTUBS initiated coverage on PRA Health Sciences (NASDAQ: PRAH) with a Buy rating and a price target of $28.00.
For an analyst ratings summary and ratings history on PRA Health Sciences click here. For more ratings news on PRA Health Sciences click here.
Shares of PRA Health Sciences closed at $22.06 yesterday.
... MoreBaird Starts PRA Health Sciences (PRAH) at Outperform
December 8, 2014 7:54 AM ESTBaird initiated coverage on PRA Health Sciences (NASDAQ: PRAH) with an Outperform rating and a price target of $28.00.
For an analyst ratings summary and ratings history on PRA Health Sciences click here. For more ratings news on PRA Health Sciences click here.
Shares of PRA Health Sciences closed at $22.06 yesterday.
... MoreWells Fargo Starts PRA Health Sciences (PRAH) at Outperform
December 8, 2014 7:54 AM ESTWells Fargo initiated coverage on PRA Health Sciences (NASDAQ: PRAH) with an Outperform rating and a price target of $25-$26.
For an analyst ratings summary and ratings history on PRA Health Sciences... More
Jefferies Starts PRA Health Sciences (PRAH) at Buy
December 8, 2014 7:42 AM ESTJefferies initiates coverage on PRA Health Sciences (NASDAQ: PRAH) with a Buy rating and a price target of $27.00.
Analyst David Windley comments, "PRA's project-based and functional service solutions combined with the additive RPS client base offer significant cross-selling opportunities and the potential for... More
